Harnessing the diversity and potential of endogenous skeletal stem cells for musculoskeletal tissue regeneration
Stem Cells · 2025
DOI: 10.1093/stmcls/sxaf006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells, 2025. Verfasst von Kelly C Weldon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, United States. Hauptthemen laut MEDLINE: Stem Cells, Regeneration, Bone Regeneration, Bone and Bones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, CIRM.
Abstract (Originalsprache)
In our aging society, the degeneration of the musculoskeletal system and adjacent tissues is a growing orthopedic concern. As bones age, they become more fragile, increasing the risk of fractures and injuries. Furthermore, tissues like cartilage accumulate damage, leading to widespread joint issues. Compounding this, the regenerative capacity of these tissues declines with age, exacerbating the consequences of fractures and cartilage deterioration. With rising demand for fracture and cartilage repair, bone-derived stem cells have attracted significant research interest. However, the therapeutic use of stem cells has produced inconsistent results, largely due to ongoing debates and uncertainties regarding the precise identity of the stem cells responsible for musculoskeletal growth, maintenance and repair. This review focuses on the potential to leverage endogenous skeletal stem cells (SSCs)—a well-defined population of stem cells with specific markers, reliable isolation techniques, and functional properties—in bone repair and cartilage regeneration. Understanding SSC behavior in response to injury, including their activation to a functional state, could provide insights into improving treatment outcomes. Techniques like microfracture surgery, which aim to stimulate SSC activity for cartilage repair, are of particular interest. Here, we explore the latest advances in how such interventions may modulate SSC function to enhance bone healing and cartilage regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, United States.
- School of Medicine, University of California, Sacramento, CA 95817, United States.
- Department of Surgery, Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA 94305, United States.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.
ORCID-Profile: Thomas H Ambrosi
Förderung
- NIH HHS
- NIA NIH HHS
- CIRM
- NIDCR NIH HHS
- NIH
- The Hagey Laboratory for Pediatric Regenerative Medicine
- Wu Tsai Human Performance Alliance
- NIA
Zitieren
APA
Weldon, K. C., Longaker, M. T., & Ambrosi, T. H. (2025). Harnessing the diversity and potential of endogenous skeletal stem cells for musculoskeletal tissue regeneration. Stem Cells. https://doi.org/10.1093/stmcls/sxaf006
Vancouver
Weldon KC, Longaker MT, Ambrosi TH. Harnessing the diversity and potential of endogenous skeletal stem cells for musculoskeletal tissue regeneration. Stem Cells. 2025. doi:10.1093/stmcls/sxaf006
BibTeX
@article{Weldon2025,
author = {Weldon, Kelly C and Longaker, Michael T and Ambrosi, Thomas H},
title = {Harnessing the diversity and potential of endogenous skeletal stem cells for musculoskeletal tissue regeneration},
journal = {Stem Cells},
year = {2025},
doi = {10.1093/stmcls/sxaf006}
}
EUVIMED